Previous 10 | Next 10 |
WORCESTER, Mass. and MUNICH, Germany, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hema...
Fortress Bio controls a network of companies that are engaged in drug development activities. The company identifies early stage assets, and helps to develop them, guide them through the clinical trial process, and manage commercialisation activities. Most of its deals are structu...
Mustang Bio (MBIO): Q3 GAAP EPS of -$0.23 beats by $0.02.Cash, cash equivalents and restricted cash of $76.3M.Press Release For further details see: Mustang Bio EPS beats by $0.02
WORCESTER, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, sol...
WORCESTER, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, sol...
Top Penny Stocks To Watch Right Now Whether you’ve got your list of penny stocks to buy right now or just making a watch list, this week will definitely be one to remember. The major markets are selling off thanks to new COVID cases across the U.S. This has put a bit of a lid...
Mustang Bio (MBIO) presents one patient‘s experience on the Phase 1 trial of MB-105, a prostate stem cell antigen ((PSCA)) chimeric antigen receptor ((CAR)) T administered to patients with PSCA-positive metastatic castration-resistant prostate cancer (mCRPC) at the virtual 27th Annual ...
WORCESTER, Mass., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, sol...
Are These Biotech Penny Stocks On Your Watch List Right Now? While there is no “remdesivir stock”, a breakout in Gilead stock has turned attention to biotech; more specifically biotech penny stocks . Thursday afternoon the company announced the U.S. FDA approved the an...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadThe earnings season heats up next week, with high-fliers Netflix (NASDAQ:NFLX), Tesla (NASDAQ:TSLA) and Chipotle (NYSE:CM...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB). The update note includes information on the Enveric Bioscience’s ma...
WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficul...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...